Extensive drug resistance in malaria and tuberculosis

Drug resistance in malaria and in tuberculosis (TB) are major global health problems. Although the terms multidrug-resistant TB and extensively drug-resistant TB are precisely defined, the term multidrug resistance is often loosely used when discussing malaria. Recent declines in the clinical effect...

Full description

Saved in:
Bibliographic Details
Published inEmerging infectious diseases Vol. 16; no. 7; pp. 1063 - 1067
Main Authors Wongsrichanalai, Chansuda, Varma, Jay K, Juliano, Jonathan J, Kimerling, Michael E, MacArthur, John R
Format Journal Article
LanguageEnglish
Published United States Centers for Disease Control and Prevention 01.07.2010
Subjects
antimicrobial resistance
CME
Drug Resistance
Drug Resistance, Bacterial
Drug Resistance, Multiple
Humans
Malaria
Malaria - drug therapy
perspective
Public Health
Tuberculosis - drug therapy
tuberculosis and other mycobacteria
Online AccessGet full text

Cover

More Information
Summary:Drug resistance in malaria and in tuberculosis (TB) are major global health problems. Although the terms multidrug-resistant TB and extensively drug-resistant TB are precisely defined, the term multidrug resistance is often loosely used when discussing malaria. Recent declines in the clinical effectiveness of antimalarial drugs, including artemisinin-based combination therapy, have prompted the need to revise the definitions of and/or to recategorize antimalarial drug resistance to include extensively drug-resistant malaria. Applying precise case definitions to different levels of drug resistance in malaria and TB is useful for individual patient care and for public health.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1080-6040
1080-6059
DOI:10.3201/eid1607.091840